Literature DB >> 27755009

Distinguishing Between Hepatosplenic T-cell Lymphoma and γδ T-cell Large Granular Lymphocytic Leukemia: A Clinicopathologic, Immunophenotypic, and Molecular Analysis.

Mariko Yabe1, L Jeffrey Medeiros, Sa A Wang, Guilin Tang, Carlos E Bueso-Ramos, Jeffrey L Jorgensen, Govind Bhagat, Weina Chen, Shaoying Li, Ken H Young, Roberto N Miranda.   

Abstract

Hepatosplenic T-cell lymphoma (HSTCL) is a rare, aggressive T-cell lymphoma that can be challenging to diagnose. In particular, distinguishing HSTCL from T-cell large granular lymphocytic (T-LGL) leukemia of γδ T-cell receptor (TCR) type is difficult without examination of a splenectomy specimen. In this study, we systematically assessed a series of HSTCL cases for findings reported in the literature as supporting or not supporting the diagnosis of HSTCL. We also compared HSTCL with a group of cases of T-LGL of γδ TCR type. Criteria assessed in this study included: B-symptoms, massive splenomegaly, lymphadenopathy, extranodal involvement, peripheral lymphocytosis, lymphoma cells that expand bone marrow sinuses, lymphocyte azurophilic granules, immunophenotype, evidence of infection by Epstein-Barr virus, human immunodeficiency virus, or human T-cell leukemia virus type 1, isochromosome 7q, trisomy 8, and TCR gene rearrangement status. On the basis of the data of this study, we conclude that massive splenomegaly, bone marrow sinusoidal expansion by lymphoma cells, and lymphocytes devoid of azurophilic granules were significantly more common in HSTCL patients than in γδ T-LGL patients (P<0.0001), and these features help support the diagnosis of HSTCL.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 27755009     DOI: 10.1097/PAS.0000000000000743

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  9 in total

1.  Hepatosplenic T cell lymphoma presenting as multiorgan failure.

Authors:  Puraskar Pateria; Annalise Martin; Tze Sheng Khor; Vanoo Jayasekeran
Journal:  BMJ Case Rep       Date:  2019-03-21

2.  Defining TCRγδ lymphoproliferative disorders by combined immunophenotypic and molecular evaluation.

Authors:  Antonella Teramo; Andrea Binatti; Elena Ciabatti; Gianluca Schiavoni; Giulia Tarrini; Gregorio Barilà; Giulia Calabretto; Cristina Vicenzetto; Vanessa Rebecca Gasparini; Monica Facco; Iacopo Petrini; Roberto Grossi; Nadia Pisanti; Stefania Bortoluzzi; Brunangelo Falini; Enrico Tiacci; Sara Galimberti; Gianpietro Semenzato; Renato Zambello
Journal:  Nat Commun       Date:  2022-06-08       Impact factor: 17.694

Review 3.  Hepatosplenic T-cell lymphoma: a rare but challenging entity.

Authors:  Barbara Pro; Pamela Allen; Amir Behdad
Journal:  Blood       Date:  2020-10-29       Impact factor: 22.113

4.  CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course.

Authors:  Zhihong Hu; Yi Sun; Ellen J Schlette; Guilin Tang; Shaoying Li; Jie Xu; C Cameron Yin; Ken H Young; Keyur Pravinchandra Patel; Roberto N Miranda; Maitrayee Goswami; Michael Wang; Jeffrey L Jorgensen; L Jeffrey Medeiros; Sa A Wang
Journal:  Mod Pathol       Date:  2017-10-06       Impact factor: 7.842

5.  γδ T-Cell Acute Lymphoblastic Leukemia/Lymphoma: Discussion of Two Pediatric Cases and Its Distinction from Other Mature γδ T-Cell Malignancies.

Authors:  Eric X Wei; Vasiliki Leventaki; John K Choi; Susana C Raimondi; Elizabeth M Azzato; Sheila A Shurtleff; Menchu G Ong; Diana M Veillon; James D Cotelingam; Rodney E Shackelford
Journal:  Case Rep Hematol       Date:  2017-09-24

6.  Flow Cytometric Pattern of TCRVδ Subtype Expression Rapidly Identifies γδT Cell Lymphoma.

Authors:  Xiao Chen; Sishu Zhao; Lu Liu; Chun Qiao; Yan Wang; Lei Fan; Huimin Jin; Yujie Wu
Journal:  Front Oncol       Date:  2020-06-16       Impact factor: 6.244

7.  Survival Analysis of Hepatosplenic T Cell Lymphoma: A Population-Based Study Using SEER.

Authors:  Yajun Li; Kailin Chen; Chaohui Zuo; Ruolan Zeng; Yizi He; Xiaoyan Chen; Ling Xiao; Hui Zhou
Journal:  Int J Gen Med       Date:  2021-11-17

Review 8.  Mature T-Cell leukemias: Challenges in Diagnosis.

Authors:  Dima El-Sharkawi; Ayoma Attygalle; Claire Dearden
Journal:  Front Oncol       Date:  2022-03-09       Impact factor: 6.244

9.  Secondary Gamma-Delta T-Cell Lymphoma Not Otherwise Specified (NOS) From Chronic Immunosuppression.

Authors:  Madeleine E Turcotte; Amar H Kelkar; Joanna Chaffin; Nam H Dang
Journal:  Cureus       Date:  2021-05-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.